Compare to
In Retatrutide diabetes research, investigators are asking whether adding glucagon receptor activity to GLP-1 and GIP receptor activity can improve metabolic outcomes without unacceptable safety trade-offs
TrimRX patients are not told upfront whether their chart is being reviewed by an MD, DO, NP, or PA, which can matter if a patient wants to understand who is handling contraindications, prior medication history, or dose-escalation decisions
Your doctor may change the dose of your other medications whilst taking Wegovy to make sure its safe for you to take
MARTA WOSINSKA: We're in a scenario where the manufacturers are new to the market, and they have a product that's protected by patents
For someone who weighs 250 pounds, that could mean losing 30 to 50 pounds with medical support